In silico identification of chikungunya virus replication inhibitor validated using biochemical and cell‐based approaches

Documenti analoghi

• Psoralidin acts as a dual protease inhibitor against PL pro and M pro of SARS ‐ CoV ‐2
  di: Aditya Trivedi, et al.
  Pubblicazione: (2025)
• Caspase‐1/11 controls Zika virus replication in astrocytes by inhibiting glycolytic metabolism
  di: Ingrid S. de Farias, et al.
  Pubblicazione: (2025)
• Compromised DNA replication in gut cells underlies sensitivity to genotoxic stress in the tardigrade Hypsibius exemplaris
  di: Gonzalo Quiroga‐Artigas, et al.
  Pubblicazione: (2026)
• In vivo and in silico models of Drosophila for Parkinson's disease
  di: Müberra Fatma Cesur, et al.
  Pubblicazione: (2025)
• Deubiquitinase inhibitors: Targeting SARS ‐ CoV ‐2 papain‐like protease with antiviral efficacy in a murine model
  di: Shweta Choudhary, et al.
  Pubblicazione: (2026)